Enterprise Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $939K | Sell |
24,455
-161
| -0.7% | -$6.18K | 0.35% | 58 |
|
2025
Q1 | $954K | Sell |
24,616
-2,276
| -8% | -$88.2K | 0.37% | 57 |
|
2024
Q4 | $909K | Buy |
26,892
+791
| +3% | +$26.8K | 0.3% | 61 |
|
2024
Q3 | $1.07M | Buy |
26,101
+493
| +2% | +$20.2K | 0.34% | 55 |
|
2024
Q2 | $986K | Buy |
25,608
+824
| +3% | +$31.7K | 0.34% | 58 |
|
2024
Q1 | $1.06M | Sell |
24,784
-473
| -2% | -$20.3K | 0.36% | 55 |
|
2023
Q4 | $936K | Buy |
25,257
+3,219
| +15% | +$119K | 0.33% | 58 |
|
2023
Q3 | $799K | Buy |
22,038
+255
| +1% | +$9.24K | 0.33% | 59 |
|
2023
Q2 | $776K | Buy |
21,783
+301
| +1% | +$10.7K | 0.3% | 64 |
|
2023
Q1 | $764K | Buy |
21,482
+629
| +3% | +$22.4K | 0.33% | 62 |
|
2022
Q4 | $733K | Buy |
+20,853
| New | +$733K | 0.35% | 63 |
|